Yanan Zhang

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Discovery of arylsulfonamides as dual orexin receptor agonists

Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice

Activation of trace amine-associated receptor 1 selectively attenuates the reinforcing effects of morphine

Neuropeptide FF and its receptors: Therapeutic applications and ligand development

Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates

TAAR 1 agonists attenuate extended access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking

Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization

Diaryl purine derivatives with improved bioavailability

Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights

Therapeutics development for addiction: Orexin-1 receptor antagonists

Synthesis and pharmacological evaluation of 1-phenyl-3-thiophenylurea derivatives as cannabinoid type-1 receptor allosteric modulators

Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats

Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: Current approaches for therapeutics development

Hypocretin Receptor 1 Regulation of Dopamine Neurotransmission and Motivated Behavior

Diarylureas containing 5-membered heterocycles as cb1 receptor allosteric modulators: Design, synthesis, and pharmacological evaluation

Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects

Synthesis of Enantiopure PZM21, A Novel Biased Agonist of the Mu-Opioid Receptor: A biased agonist of the mu-opioid receptor

The imidazoline I-2 receptor agonist 2-BFI attenuates hypersensitivity and spinal neuroinflammation in a rat model of neuropathic pain

Blocking alcoholic steatosis in mice with a peripherally restricted purine antagonist of the type 1 cannabinoid receptor

Neuroanatomical characterization of imidazoline I-2 receptor agonist-induced antinociception